Literature DB >> 32978173

Examining COVID-19 Preventive Behaviors among Cancer Survivors in the United States: An Analysis of the COVID-19 Impact Survey.

Jessica Y Islam1, Marlene Camacho-Rivera2, Denise C Vidot3.   

Abstract

BACKGROUND: The COVID-19 pandemic has impacted adults with chronic diseases, and their health care delivery. Patterns of COVID-19-related preventive behaviors practiced by cancer survivors are unknown, including practices related to canceling doctor's appointments. We evaluated COVID-19-related preventive behaviors among cancer survivors in the United States.
METHODS: We used nationally representative data of 10,760 U.S. adults from the COVID-19 Impact Survey. We defined cancer survivors as those with a self-reported diagnosis of cancer (n = 854, 7.6%). We present frequencies and χ2 tests to evaluate COVID-19-related preventive behaviors among cancer survivors. We estimated determinants of canceling doctor's appointments among cancer survivors using Poisson regression models.
RESULTS: Cancer survivors were more likely to practice preventive behaviors, including social distancing (93%, χ2 P < 0.001), wearing a face mask (93%, χ2 P < 0.001), and avoiding crowded areas (84%, χ2 P < 0.001) compared with adults without cancer. Cancer survivors were more likely to cancel doctor's appointments (41%, χ2 P < 0.001), whereas they were less likely to cancel other social activities such as work (19%, χ2 P < 0.001) and school-related (13%, χ2 P < 0.001) activities. After adjustment for covariates, while non-Hispanic (NH)-Black cancer survivors were less likely to cancel a doctor's appointment compared with NH-White cancer survivors, cancer survivors aged 18 to 29, who were female, and who had least one comorbid condition were more likely.
CONCLUSIONS: Cancer survivors are adhering to recommended preventive behaviors. Cancer survivor's continuity of care may be impacted by COVID-19, specifically young adults, females, and those with existing comorbid conditions. IMPACT: Insights into cancer survivors whose care may be most impacted by COVID-19 will be valuable toward surveillance and survivorship of U.S. cancer survivors. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2020        PMID: 32978173     DOI: 10.1158/1055-9965.EPI-20-0801

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  12 in total

1.  Cancer survivors' perceived vulnerability to COVID-19 and impacts on cognitive, affective, and behavioral responses to the pandemic.

Authors:  Elizabeth T Slivjak; Joel N Fishbein; Madeline Nealis; Sarah J Schmiege; Joanna J Arch
Journal:  J Psychosoc Oncol       Date:  2021-04-22

2.  Preventive Behaviors and Mental Health-Related Symptoms Among Immunocompromised Adults During the COVID-19 Pandemic: An Analysis of the COVID Impact Survey.

Authors:  Jessica Yasmine Islam; Denise Christina Vidot; Amoghvarsha Havanur; Marlene Camacho-Rivera
Journal:  AIDS Res Hum Retroviruses       Date:  2021-04       Impact factor: 2.205

3.  Evaluating Mental Health-Related Symptoms Among Cancer Survivors During the COVID-19 Pandemic: An Analysis of the COVID Impact Survey.

Authors:  Jessica Yasmine Islam; Denise C Vidot; Marlene Camacho-Rivera
Journal:  JCO Oncol Pract       Date:  2021-01-22

4.  Factors associated with self-reported social isolation among patients with cancer during the COVID-19 pandemic.

Authors:  Cassandra A Hathaway; Amanda M Bloomer; Laura B Oswald; Erin M Siegel; Anita R Peoples; Cornelia M Ulrich; Frank J Penedo; Shelley S Tworoger; Brian D Gonzalez
Journal:  Health Psychol       Date:  2022-04       Impact factor: 5.556

5.  Identifying and describing cancer survivors: Implications for cancer survivorship research and clinical care.

Authors:  Michelle Doose; Michelle A Mollica; Deanna J Attai; Shelley Fuld Nasso; Joanne W Elena; Paul B Jacobsen; Emily S Tonorezos; Larissa Nekhlyudov
Journal:  Cancer       Date:  2021-10-01       Impact factor: 6.921

Review 6.  Oncofertility and COVID-19: At the Crossroads between Two Time-Sensitive Fields.

Authors:  Valentin Nicolae Varlas; Roxana Georgiana Borș; Anca Lucia Pop; Bogdana Adriana Năsui; Nicolae Bacalbasa; Roxana Bohîlțea; Radu Vlădăreanu; Corina Manolea
Journal:  J Clin Med       Date:  2022-02-24       Impact factor: 4.241

7.  Impact of the COVID-19 pandemic on rural and urban cancer patients' experiences, health behaviors, and perceptions.

Authors:  Anita R Peoples; Laura B Oswald; Jennifer Ose; Bailee Daniels; Caroline Himbert; Cassandra A Hathaway; Biljana Gigic; Anne C Kirchhoff; Tengda Lin; Douglas Grossman; Jonathan Tward; Thomas K Varghese; Jane C Figueiredo; Adetunji T Toriola; Anna Beck; Courtney Scaife; David Shibata; Paul LaStayo; Brian Gonzalez; Karen Salas; Anjelica Ashworth; Cindy Matsen; Cristina Christenson; Debra S Ma; Howard Colman; Jason P Hunt; Kevin B Jones; Catherine J Lee; Mikaela Larson; Tracy Onega; Wallace L Akerley; Christopher I Li; Martin Schneider; Frank J Penedo; Erin M Siegel; Shelley S Tworoger; Cornelia M Ulrich
Journal:  J Rural Health       Date:  2022-03-03       Impact factor: 5.667

8.  Adherence to Coronavirus Disease 2019 Preventive Measures in a Representative Sample of the Population of the Canton of Vaud, Switzerland.

Authors:  Audrey Butty; Nolwenn Bühler; Jérôme Pasquier; Julien Dupraz; Vincent Faivre; Sandrine Estoppey; Cloé Rawlinson; Semira Gonseth Nusslé; Murielle Bochud; Valérie D'Acremont
Journal:  Int J Public Health       Date:  2022-08-25       Impact factor: 5.100

9.  Readdressing the Needs of Cancer Survivors During COVID-19: A Path Forward.

Authors:  Jennifer M Jones; Hina Saeed; Matthew S Katz; Maryam B Lustberg; Victoria J Forster; Larissa Nekhlyudov
Journal:  J Natl Cancer Inst       Date:  2021-08-02       Impact factor: 13.506

10.  Cannabis Use among Cancer Survivors amid the COVID-19 Pandemic: Results from the COVID-19 Cannabis Health Study.

Authors:  Marlene Camacho-Rivera; Jessica Y Islam; Diane L Rodriguez; Denise C Vidot
Journal:  Cancers (Basel)       Date:  2021-07-13       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.